ArticleClinics (Sao Paulo, Brazil)2026
Effects of transcutaneous vagus nerve stimulation on motor function in older adults: a randomized crossover study.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAging is associated with declines in gait performance and autonomic regulation, increasing the risk of functional limitations. Auricular transcutaneous Vagus Nerve Stimulation (tVNS) is a promising non-pharmacological intervention, but its acute effects on gait in older adults remain unclear. This study investigates whether acute tVNS can improve gait performance and autonomic function in healthy community-dwelling older women.
methodsA prospective, randomized, blinded, crossover trial was conducted with 17 healthy older women (≥60-years). Participants received active tVNS (left ear, 25 Hz, 500 μs, 30-min) and sham stimulation (right earlobe), separated by a 24-hour washout period. The primary outcome was the distance covered on the 6-Minute Walk Test (6MWT). Heart Rate Variability (HRV) was assessed as a key secondary outcome.
findingsActive tVNS significantly increased the resting Inter-Beat Interval (IBI, p = 0.008) and reduced heart rate (p = 0.03), indicating enhanced parasympathetic modulation. Sympathetic activity (LF and LF/HF ratio) decreased following active stimulation. Although absolute 6MWT distance did not significantly change (p = 0.07), the predicted walking distance improved significantly with active tVNS compared to sham (p < 0.01; Cohen's d = 0.65; mean difference -7.2%). Other clinical parameters remained unchanged.
interpretationThis first randomized crossover trial investigating the acute effects of transcutaneous vagus nerve stimulation in healthy older women demonstrated enhanced parasympathetic modulation and improved performance relative to predicted walking capacity. However, the primary outcome, absolute 6-minute walk distance, did not reach statistical significance. These findings should therefore be considered preliminary and hypothesis-generating, supporting the need for larger trials to determine the long-term clinical relevance of tVNS in older populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.